BLK:NYSEBlackRock, Inc. Analysis
Data as of 2026-08-12 - not real-time
$1,148.84
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
At $1,148.84, BlackRock, Inc. shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have gained 20.9%. Relative strength is 67.1 — approaching overbought — and the MACD signal is bullish. Price has been bracketed by support at $1,030.93 and resistance at $1,152.80.
Multiples put this in overvalued territory: 27.1 times earnings against the sector's 16.9. Analyst price targets sit 14.4% above the current price. Revenue is growing at 30.6% on a 24.1% profit margin. The 2.03% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 29.9%, a beta of 1.17 and a maximum drawdown of 23.3%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Multiples put this in overvalued territory: 27.1 times earnings against the sector's 16.9. Analyst price targets sit 14.4% above the current price. Revenue is growing at 30.6% on a 24.1% profit margin. The 2.03% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 29.9%, a beta of 1.17 and a maximum drawdown of 23.3%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Top Market Events
NEW YORK, July 15, 2026--BlackRock, Inc. NYSE: BLK today released its financial results for the second quarter of 2026....BlackRock Inc BLK reports robust growth with record net inflows and revenue, while navigating increased expenses and...Influence Media Partners, backed by BlackRock, has agreed to acquire Anthem Entertainment's music publishing catalogs...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 1053.24
- MACD momentum is positive
- 30-day price change of +20.9%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 27.1 versus sector average of 16.9
- Trading above the 200-day average of 1053.24
- Analyst targets imply +14.4% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 27.1 versus sector average of 16.9
- Analyst targets imply +14.4% versus the current price
- Profit margin of 24.1% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth30.60%
Profit Margin24.09%
P/E Ratio27.1
ROE12.28%
ROA3.74%
Debt/Equity23.19
P/B Ratio3.1
Op. Cash Flow$3.9B
Free Cash Flow$7.6B
Industry P/E16.9
Technical Analysis
TrendNeutral
RSI67.1
Support$1,030.93
Resistance$1,152.80
MA 20$1,092.97
MA 50$1,043.49
MA 200$1,053.24
MACDBullish
VolumeDecreasing
Fear & Greed Index94.13
Valuation
Fair Value$1,614.61
Target Price$1,314.44
Upside/Downside14.41%
GradeOvervalued
TypeBlend
Dividend Yield2.03%
Risk Assessment
Beta1.17
Volatility29.93%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.